Member Info for notrac

Did anyone listen to the presentation yesterday? Was there any mention of sales in the current quarter? Current shareholders need to bone up on the history of this company. The share price peaked at 180p in 2019.

That closes the gap caused by going ex-div on August 15th.

No overall change on yesterday's close.

Recently the share price price has been treading water after a great run since the election.

The decline in the MXN vs USD should be really positive for FRES.

Why the drop?

Is bearish on CGS . Anyone know why?

Strange RNS. There's no mention of any discussions with any third party. This looks a strategem to push the share price up.

Hopefully this will bring an end to the carry trade between JPY and MXN. Should be good for FRES:

The data feeds are not picking up the Nil Paids yet. I recall that there was a fair amount of volatility in RR's Nil Paids during its Rights Issue.

This must start very soon. Last years finals were issued around July 20th.

Confirmed.

Nothing to do with SCIR exiting from AIM?

Momentum quarter on quarter is slowing, that's why.

What are Bank of America doing?. They're rumoured to have a massive short in Silver . Above $26 is nosebleed territory for them.

I see the directors are exercising their options before the share goes ex-div in a couple of weeks.

In my view the problem is the MXNJPY exchange rate. Although the Japanese have now abandoned negative interest rates, the carry trade is alive and well where people sell yen and buy MXN because of the interest rate differential. FRES's costs are in MXN and the revenues are in dollars. Until the MXN interest rate differential starts to ease, FRES will struggle even though the price of silver and gold are going in the right direction.

Bought first thing. Couldn't believe that the price had not opened higher than last night's close.

Invest in a share which is a contributor to the UK's lazy and unhealthy eating habits resulting in further costs for the NHS.

It would be good to know AST's cash position.